Its San Diego and Palo Alto lawyers advised the drug developer, which focuses on treatments for ear disorders and diseases.
August 13, 2014 at 05:26 PM
1 minute read
SAN FRANCISCO — Wilson Sonsini Goodrich & Rosati advised San Diego-based therapeutics company Otonomy Inc. in its initial public offering, the firm announced Wednesday.
The drug developer, focused on treating ear disorders and diseases, registered 6.25 million shares of public common stock at $16 per share. It began trading Wednesday on the Nasdaq Global Select Market under the symbol “OTIC.”
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
